Autor der Publikation

(3)HMRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors

, , , , , , , , , und . Mol Pharmacol, 57 (5): 968-75 (Mai 2000)Varani, K Merighi, S Gessi, S Klotz, K N Leung, E Baraldi, P G Cacciari, B Romagnoli, R Spalluto, G Borea, P A United states Molecular pharmacology Mol Pharmacol. 2000 May;57(5):968-75..

Bitte wählen Sie eine Person um die Publikation zuzuordnen

Um zwischen Personen mit demselben Namen zu unterscheiden, wird der akademische Grad und der Titel einer wichtigen Publikation angezeigt. Zudem lassen sich über den Button neben dem Namen einige der Person bereits zugeordnete Publikationen anzeigen.

 

Weitere Publikationen von Autoren mit dem selben Namen

(3)HMRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors, , , , , , , , , und . Mol Pharmacol, 57 (5): 968-75 (Mai 2000)Varani, K Merighi, S Gessi, S Klotz, K N Leung, E Baraldi, P G Cacciari, B Romagnoli, R Spalluto, G Borea, P A United states Molecular pharmacology Mol Pharmacol. 2000 May;57(5):968-75..Synthesis, biological activity, and molecular modeling investigation of new pyrazolo4,3-e-1,2,4-triazolo1,5-cpyrimidine derivatives as human A(3) adenosine receptor antagonists, , , , , , , , , und . J Med Chem, 45 (4): 770-80 (Februar 2002)Baraldi, Pier Giovanni Cacciari, Barbara Moro, Stefano Spalluto, Giampiero Pastorin, Giorgia Da Ros, Tatiana Klotz, Karl-Norbert Varani, Katia Gessi, Stefania Borea, Pier Andrea Research Support, Non-U.S. Gov't United States Journal of medicinal chemistry J Med Chem. 2002 Feb 14;45(4):770-80..Exploring potency and selectivity receptor antagonist profiles using a multilabel classification approach: the human adenosine receptors as a key study, , , , , , , , und . J Chem Inf Model, 49 (12): 2820-36 (Dezember 2009)Michielan, Lisa Stephanie, Federico Terfloth, Lothar Hristozov, Dimitar Cacciari, Barbara Klotz, Karl-Norbert Spalluto, Giampiero Gasteiger, Johann Moro, Stefano Research Support, Non-U.S. Gov't United States Journal of chemical information and modeling J Chem Inf Model. 2009 Dec;49(12):2820-36..Synthesis, biological studies and molecular modeling investigation of 1,3-dimethyl-2,4-dioxo-6-methyl-8-(substituted) 1,2,3,4-tetrahydro 1,2,4-triazolo 3,4-f-purines as potential adenosine receptor antagonists, , , , , , , und . Farmaco, 60 (4): 299-306 (April 2005)Pastorin, Giorgia Bolcato, Chiara Cacciari, Barbara Kachler, Sonja Klotz, Karl-Norbert Montopoli, Christian Moro, Stefano Spalluto, Giampiero Research Support, Non-U.S. Gov't Italy Farmaco (Societa chimica italiana : 1989) Farmaco. 2005 Apr;60(4):299-306..Pyrazolo-triazolo-pyrimidines as adenosine receptor antagonists: A complete structure-activity profile, , , , , , und . Purinergic Signal, 3 (3): 183-93 (Juni 2007)Cacciari, Barbara Bolcato, Chiara Spalluto, Giampiero Klotz, Karl-Norbet Bacilieri, Magdalena Deflorian, Francesca Moro, Stefano Netherlands Purinergic signalling Purinergic Signal. 2007 Jun;3(3):183-93. Epub 2006 Nov 14..Pyrazolo-triazolo-pyrimidines as adenosine receptor antagonists: Effect of the N-5 bond type on the affinity and selectivity at the four adenosine receptor subtypes, , , , , , , und . Purinergic Signal, 4 (1): 39-46 (März 2008)Bolcato, Chiara Cusan, Claudia Pastorin, Giorgia Spalluto, Giampiero Cacciari, Barbara Klotz, Karl Norbert Morizzo, Erika Moro, Stefano Netherlands Purinergic signalling Purinergic Signal. 2008 Mar;4(1):39-46. Epub 2007 Jul 25..Synthesis, biological and modeling studies of 1,3-di-n-propyl-2,4-dioxo-6-methyl-8-(substituted) 1,2,3,4-tetrahydro 1,2,4-triazolo 3,4-f-purines as adenosine receptor antagonists, , , , , , , und . Farmaco, 60 (8): 643-51 (August 2005)Pastorin, G Bolcato, C Cacciari, B Kachler, S Klotz, K-N Montopoli, C Moro, S Spalluto, G Research Support, Non-U.S. Gov't France Farmaco (Societa chimica italiana : 1989) Farmaco. 2005 Aug;60(8):643-51..Pyrazolo4,3-e1,2,4-triazolo1,5-cpyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonists: influence of the chain at the N(8) pyrazole nitrogen, , , , , , , , , und 1 andere Autor(en). J Med Chem, 43 (25): 4768-80 (Dezember 2000)Baraldi, P G Cacciari, B Romagnoli, R Spalluto, G Moro, S Klotz, K N Leung, E Varani, K Gessi, S Merighi, S Borea, P A Research Support, Non-U.S. Gov't United states Journal of medicinal chemistry J Med Chem. 2000 Dec 14;43(25):4768-80..Pyrazolo4,3-e-1,2,4-triazolo1,5-cpyrimidine derivatives as highly potent and selective human A(3) adenosine receptor antagonists, , , , , , , , , und . J Med Chem, 42 (22): 4473-8 (November 1999)Baraldi, P G Cacciari, B Romagnoli, R Spalluto, G Klotz, K N Leung, E Varani, K Gessi, S Merighi, S Borea, P A In Vitro Research Support, Non-U.S. Gov't United states Journal of medicinal chemistry J Med Chem. 1999 Nov 4;42(22):4473-8..Combining selectivity and affinity predictions using an integrated Support Vector Machine (SVM) approach: An alternative tool to discriminate between the human adenosine A(2A) and A(3) receptor pyrazolo-triazolo-pyrimidine antagonists binding sites, , , , , , , , , und 2 andere Autor(en). Bioorg Med Chem, 17 (14): 5259-74 (Juli 2009)Michielan, Lisa Bolcato, Chiara Federico, Stephanie Cacciari, Barbara Bacilieri, Magdalena Klotz, Karl-Norbert Kachler, Sonja Pastorin, Giorgia Cardin, Riccardo Sperduti, Alessandro Spalluto, Giampiero Moro, Stefano Research Support, Non-U.S. Gov't England Bioorganic & medicinal chemistry Bioorg Med Chem. 2009 Jul 15;17(14):5259-74. Epub 2009 May 21..